All Companies

ABTCongressional Stock Trades

Abbott Laboratories

Pharmaceutical Preparations

Congressional stock trades in Abbott Laboratories (ABT) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

Total Trades

51

Politicians Trading

20

Last Traded

Oct 2, 2026

Trading History

PoliticianNotifiedTradedTypeAmountChange
Pete SessionsROct 27, 2026Oct 2, 2026Sell$50,001 - $100,000+12.98%
Rick W. AllenRAug 18, 2026Jul 14, 2026Sell$15,001 - $50,000+23.83%
Richard McCormickRAug 14, 2026Jul 30, 2026Sell$1,001 - $15,000+4.31%
Mike KellyRAug 12, 2026Jul 17, 2026Sell$1,001 - $15,000+9.42%
Alan ArmstrongRJul 21, 2026Mar 27, 2026Sell$15,001 - $50,000+5.93%
Julia LetlowRJan 13, 2026Dec 8, 2025Sell$1,001 - $15,000-9.77%
Byron DonaldsRJan 7, 2026Dec 4, 2025Sell$1,001 - $15,000-12.15%
Byron DonaldsRJan 7, 2026Dec 4, 2025Sell$1,001 - $15,000-12.15%
Lisa C. McClainRAug 13, 2025Jul 10, 2025Sell$1,001 - $15,000-17.54%
Jefferson ShreveRJun 22, 2025May 12, 2025Sell$50,001 - $100,000-16.54%
Bruce WestermanRMay 12, 2025Apr 21, 2025Sell$1,001 - $15,000-15.19%
Shelley Moore CapitoRMar 6, 2025Feb 24, 2025Sell$1,001 - $15,000-18.37%
Markwayne MullinRJan 31, 2025Jan 8, 2025Sell$1,001 - $15,000-3.58%

Price History

About Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

FAQ

20 members of Congress have disclosed 51 trades in Abbott Laboratories (ABT). Most active: Ro Khanna (8), Josh Gottheimer (6), Gilbert Ray Cisneros, Jr. (5).

Across all disclosures, members of Congress reported 20 purchases and 31 sales of Abbott Laboratories (ABT). The most recent trade was on Oct 2, 2026.

Gilbert Ray Cisneros, Jr. disclosed buying Abbott Laboratories (ABT) on Sep 18, 2026, valued at $1,001 - $15,000.

Pete Sessions disclosed selling Abbott Laboratories (ABT) on Oct 2, 2026, valued at $50,001 - $100,000.

From House and Senate periodic transaction reports filed under the STOCK Act. Members of Congress must disclose trades within 45 days, and amounts are reported as ranges, not exact values.